Loading...
argenx SE
ARGX•NASDAQ
HealthcareBiotechnology
$585.34
$4.75(0.82%)
argenx SE (ARGX) Financial Performance & Statements
Review argenx SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
77.27%
↑ 77.27%
Operating Income Growth
95.08%
↑ 95.08%
Net Income Growth
372.54%
↑ 372.54%
Operating Cash Flow Growth
80.31%
↑ 80.31%
Operating Margin
-1.24%
↓ 1.24%
Gross Margin
46.33%
↑ 46.33%
Net Profit Margin
37.53%
↑ 37.53%
ROE
16.50%
↑ 16.50%
ROIC
-0.48%
↓ 0.48%
argenx SE (ARGX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for argenx SE stock.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $573.24M | $877.26M | $401.001M | $407.43M |
| Cost of Revenue | $59.07M | $52.38M | $43.18M | $143.02M |
| Gross Profit | $514.16M | $824.88M | $357.82M | $264.42M |
| Gross Profit Ratio | $0.90 | $0.94 | $0.89 | $0.65 |
| R&D Expenses | $235.94M | $446.79M | $224.97M | $204.63M |
| SG&A Expenses | $277.70M | $489.50M | $236.00M | $207.85M |
| Operating Expenses | $499.98M | $936.29M | $449.45M | $412.47M |
| Total Costs & Expenses | $559.05M | $523.10M | $492.63M | $555.49M |
| Interest Income | $40.59M | $38.93M | $38.90M | $40.37M |
| Interest Expense | $676000.00 | $572000.00 | $512000.00 | $280411.00 |
| Depreciation & Amortization | $74.51M | $8.61M | $24.05M | $103.48M |
| EBITDA | $88.70M | -$36.99M | -$54.53M | -$44.57M |
| EBITDA Ratio | $0.15 | -$0.04 | -$0.14 | -$0.11 |
| Operating Income | $14.19M | -$158.63M | -$93.42M | -$148.06M |
| Operating Income Ratio | $0.02 | -$0.18 | -$0.23 | -$0.36 |
| Other Income/Expenses (Net) | $73.84M | $143.62M | $19.07M | $86.88M |
| Income Before Tax | $88.02M | -$15.003M | -$74.35M | -$59.48M |
| Income Before Tax Ratio | $0.15 | -$0.02 | -$0.19 | -$0.15 |
| Income Tax Expense | -$3.39M | -$44.07M | -$12.75M | $38.05M |
| Net Income | $91.41M | -$32.48M | -$61.60M | -$99.32M |
| Net Income Ratio | $0.16 | -$0.04 | -$0.15 | -$0.24 |
| EPS | $1.52 | -$0.55 | -$1.04 | -$1.70 |
| Diluted EPS | $1.39 | -$0.55 | -$1.04 | -$1.70 |
| Weighted Avg Shares Outstanding | $60.09M | $59.40M | $59.31M | $58.28M |
| Weighted Avg Shares Outstanding (Diluted) | $65.76M | $59.40M | $59.31M | $58.28M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan